Latest News & Features
Europe
According to the Patent Index 2024, patent filings remained high in Europe last year “despite political and economic uncertainties” | Johnson & Johnson ranked among the top requesters of unitary patents. 8 April 2025
Americas
Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations in AI and gene editing, and offers advice for thriving in a competitive environment. 8 April 2025
Europe
The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent. 8 April 2025
Careers
Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on drug cases involving Lialda, Vyvanse, and Intuniv, among others. 7 April 2025
Americas
The IP specialist bypassed vendors and turned to its own ‘tech geeks’ to create an in-house AI solution for drafting patent applications. LSIPR meets the attorney coders doing it for themselves. 3 April 2025
Europe
The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR Diversity Champion, Susi Fish, shares her experiences and tips for managing stress. 3 April 2025
Americas
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing competition and patent expiration increase urgency for Lilly | New Jersey and Delaware stores accused of selling unapproved tirzepatide-based products. 3 April 2025
Americas
MSD, Novartis and Eli Lilly are among those whose multi-billion-dollar patents are hurtling towards expiration, writes Marisa Woutersen. 1 April 2025
Careers
Leading patent litigator who worked on disputes involving Broadcom, Sonos, and Tesla joins firm’s Düsseldorf office from EIP. 1 April 2025
Europe
With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster blood thinner from generics. Marisa Woutersen finds Bayer’s outside litigation counsel ready for anything. 31 March 2025